Stage IIIB Breast Cancer Terminated Phase 1 / 2 Trials for Docetaxel (DB01248)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00063934Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast CancerTreatment